Klin Farmakol Farm. 2010;24(1):25-28

Influenza - vaccination is basis of prevention

Jiří Beran
Centrum očkování a cestovní medicíny, Poliklinika II., Hradec Králové

Influenza is an infectious viral disease that afflicts an important part of the world population every year and causes thousands of deaths all

over the world. Although vaccination is effective in influenza prevention, the immunization coverage remains low in the Czech Republic.

Vaccination against influenza is indicated primarily for high risk population groups but can be of benefit to other persons as well. Currently,

a vaccination campaign against pandemic influenza has been started by application of one or two dose (immunocompromised

patients) vaccination schedule.

Keywords: influenza, vaccination, vaccine, immunization

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beran J. Influenza - vaccination is basis of prevention. Klin Farmakol Farm. 2010;24(1):25-28.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med. 2009; 2(7): 13. Go to original source... Go to PubMed...
    2. Beran J, Wertzova V, Honegr K, Kaliskova E, Havlickova M, Havlik J, et al. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis. 2009; 17(9): 2. Go to original source... Go to PubMed...
    3. Beran J, Havlík J. Chřipka - klinický obraz- prevence-léčba 2005. Maxdorf Jesenius, 2. vyd. Praha, 175.
    4. Beran J, Moravik J. Effectiveness of vaccination against influenza in SkodaAuto Company employees during the influenza season 2000-2001. Cent Eur J Public Health. 2003; 11(4): 209-212.
    5. Bhat N, Wright JG, Broder KR, et al. Influenza assotiated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353: 2559-2567. Go to original source... Go to PubMed...
    6. Centers for Disease Control. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep 2005; 54: 1-40.
    7. Essen van GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21: 1780-1785. Go to original source... Go to PubMed...
    8. Fan J, Liang X, Horton MS, et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 2004; 22: 2993-3003. Go to original source... Go to PubMed...
    9. Gerhard W, Mozdzanowska K, Zharikova D. Prospects for Universal influenza virus Vaccine.Emerging Infectious Diseases. 2006; 12: 569-574. Go to original source... Go to PubMed...
    10. Havlíčková M, Otavová M, Kynčl J, et al. Surveillance akutních respiračních infekcí (ARI) v České Republice v sezóně 2004/2005. Zprávy centra Epidemiol Mikrobiol 2005; 14(6): 286-293.
    11. Hehme N, Engelmann H, Kunzel W, et al. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med Mikrob Immunol 2002; 191: 203-208. Go to original source... Go to PubMed...
    12. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920, ,Spanish" influenza pandemic. Bull Hist Med 2002; 76: 105-115. Go to original source... Go to PubMed...
    13. Luke CJ, Subbarao K. Vaccines for Pandemic Influenza. Emerging Infectious Diseases 2006; 12: 66-72. Go to original source... Go to PubMed...
    14. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerging Infectious Diseases 1999; 5: 659-671. Go to original source... Go to PubMed...
    15. Nicholson KG, Colegate AE, Podda A, et al. Safety and antigenicity of non-adjuvanted and MF59 - adjuvanted A/ Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 2001; 357: 1937-1943. Go to original source... Go to PubMed...
    16. Podewils JD, Liedtke LA, McDonald LC, et al. A national survey of severe influenza - assotiated complitations among children and adults. Clin Infect Dis 2005; 40: 1693-1696. Go to original source... Go to PubMed...
    17. Prevention and treatment of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000; 49(RR-3): 1-38. 2005; 191: 1210-1215.
    18. Stephenson I, Nicholson KG, Gluck R, et al. Safety and antigenicity of whole virus and subunit influenza A/HongKong/1073/99 (H9N2) vaccine in healthy adults phase I randomised trial. Lancet 2003; 362: 1959-1966. Go to original source... Go to PubMed...
    19. Szucs TD, Müller D. Influenza vaccination coverage rates in five European countries - a population based cross - sectional analysis of two consecutive influenza seasons. Vaccine 2005; 23: 5055-5063. Go to original source... Go to PubMed...
    20. Tosh PK, Boyce TG, Poland GA. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. Mayo Clin Proc. 2008; 83(1): 77-84. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.